Read More

Flora Growth’s Stock Trading Higher On Pricing $3.2M Public Offering Of Common Shares

Flora Growth Corp. announced on Thursday the pricing of its underwritten public offering of 1.7 million common shares for aggregate gross proceeds of roughly $3.23 million. Clifford Starke, the company's CEO, and an existing investor have agreed to purchase, and have been allocated by Aegis Capital Corp., Common Shares in the offering. Flora said it will use the net proceeds from the transaction that is expected to close on or about Monday, April 8 for general corporate and working capital needs. The move came on the heels of the company's latest move to further cement its global footprint via acquisition in Germany.

FLGC

Read More

Hydroponics Giant Announces $6M Share Repurchase Program, CEO Says Understanding ‘Where Every Nickel Goes’ Is Vital For Business Growth

Beginning on April 1, the share repurchase program, will continue for up to one year, allowing for repurchases to be made in the open market. Darren Lampert, the company's co-founder and CEO, explained what the move means for GrowGen. "Today's announcement of our share repurchase program further underscores our conviction in the strength of our underlying business and our view that GrowGen shares remain undervalued," Lampert said. "This program acts as one pillar of our shareholder value creation strategy as we continue to evaluate all potential uses for our strong balance sheet, including reinvesting in our brands, strategic acquisitions, and stock repurchases to enhance long-term shareholder value."

GRWG